Penumbra Inc (PEN)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$285.00

Buy

$305.00

arrow-down$-11.44 (-3.77%)

Prices updated at 22 Feb 2025, 00:57 EST
| Prices minimum 15 mins delay
|
Prices in USD

Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.

Income statement

20232024
1,059m1,195m
683m755m
92m86m
8.677.22
91m14m
109m46m
Sales, General and administrative506m574m
Interest expenses2m1m
Provision for income taxes-11m7m
Operating expenses591m669m
Income before taxes80m21m
Net income available to common shareholders91m14m
2.370.36
Net interest income5m12m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)2.320.36
Free cash flow per share1.21553.453
Book value/share28.544328.6894
Debt equity ratio0.1873790.181417

Balance sheet

20232024
Current assets915m951m
Current liabilities151m158m
Total capital1,179m1,151m
Total debt234m223m
Total equity1,179m1,151m
Total non current liabilities--
Loans--
Total assets1,556m1,533m
Total liabilities--
Cash and cash equivalents167m324m
Common stock39m38m

Cash flow

20232024
Cash at beginning of period70m167m
Cash dividends paid--
82m147m
Investments (gains) losses-16m78m
167m324m
Net income--
97m168m
-15m-21m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.